Mr. Speaker, the fact amendments are coming is a good thing. We must remember this is a big bill and it is complicated. It does not deal only with natural health products. It deals with drugs, cells, blood, cell cultures. There is a whole lot more in the bill than natural health products. It seems the biggest concerns have been in this realm.
We hope the amendments, which will be forthcoming in time for committee to take them right at the beginning of its deliberations, will help to ameliorate the situation.